Regeneron hands ex-US rights to HoFH drug Evkeeza to Ultrage...

Regeneron has enlisted the aid of Ultragenyx to add momentum to the rollout of its recently-approved Evkeeza outside the US, which was approved for an inherited form of elevated cholesterol